Publications by authors named "Ellen Ypma"

Claim this Profile
M
Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents.
Lorenzo Argante, Ottavia Prunas, Duccio Medini, Ellen Ypma

NPJ Vaccines· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing multiplicity in clinical vaccine studies - A case study using a gatekeeping testing strategy.
Huajun Wang, Ellen Ypma, Uwe Nicolay

Vaccine· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration.
Roberto Gasparini, Miguel Tregnaghi, Pavitra Keshavan, Ellen Ypma, Linda Han

Pediatr Infect Dis J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials.
Timo Vesikari, Susanna Esposito, Roman Prymula, Ellen Ypma, Igor Kohl

Lancet· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
Nicoletta Gossger, Matthew D Snape, Ly-Mee Yu, Adam Finn, Gianni Bona, Ellen Ypma

JAMA· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.
Catherine Jackson, Diana Lennon, Sharon Wong, Jacqueline Yan, Joanna Stewart, Ellen Ypma

Arch Dis Child· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.
Daniela Toneatto, Philipp Oster, A Corine W deBoer, Amy Emerson, George F Santos, Ellen Ypma

Hum Vaccin· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.
Daniela Toneatto, Shevqet Ismaili, Ellen Ypma, Kay Vienken, Philipp Oster

Hum Vaccin· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
Matthew D Snape, Tom Dawson, Philipp Oster, Anita Evans, Tessa M John, Ellen Ypma

Pediatr Infect Dis J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Jamie Findlow, Ray Borrow, Matthew D Snape, Tom Dawson, Ann Holland, Ellen Ypma

Clin Infect Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.
Sharon H Wong, Diana R Lennon, Catherine M Jackson, Joanna M Stewart, Stewart Reid, Ellen Ypma

Pediatr Infect Dis J· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants.
Heinz-J Schmitt, Katrin Simone Steul, Astrid Borkowski, Francesca Ceddia, Ellen Ypma

Vaccine· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.
Jamie Hosking, Kumanan Rasanathan, Florina Chan Mow, Catherine Jackson, Diana Martin, Ellen Ypma

Clin Vaccine Immunol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.
Ingeborg S Aaberge, Philipp Oster, Oddveig S Helland, Anne-Cathrine Kristoffersen, Ellen Ypma

Clin Diagn Lab Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy.
Luca A Fumagalli, Jan Vinke, Wilco Hoff, Ellen Ypma, Ferdinando Brivio

J Immunother· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population.
Iain Stephenson, Karl G Nicholson, Anthony Colegate, Audino Podda, John Wood, Ellen Ypma

Vaccine· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis